retatrutide and liver Researchers are reporting promising results from studies on an experimental medication called retatrutide, which may help reduce fat while improving overall metabolic health. 🧬⚡ Excess liver fat is a key feature Since January 2026, there have

Alcohol use disorder trials

People with leptin gene mutations are obese secondary to pronounced hyperphagia [84], and satiety and body weight can be regulated in people with these genetic mutations with leptin treatment [85]

Oral delivery and reduced dosing frequency are emerging differentiators that aim to improve adherence and therefore real-world outcomes. 1 Broader Drugs to Watch in 2026 Pipeline Span Oncology, Immunology, and Rare Disease Among the 11 drugs cited in the Clarivate report, no other medications were projected to exceed more than $2 billion in 2031

Notwithstanding these limitations, disproportionality analysis still remains a crucial tool for detecting potential safety signals associated with drugs and guiding further investigations [16, 29, 33, 52]

A small percentage of patients report persistent loose stools, which may indicate a need for dose adjustment or dietary modification rather than medication discontinuation

Prescription GLP-1 medications For people who qualify medically, prescription GLP-1 receptor agonists remain the gold standard for pharmaceutical weight management